Two new products unveiled by E for M:
This article was originally published in Clinica
E for M introduced MidasGold and CardioWindow for use in cath labs at the American Heart Association (Anaheim, November 13th- 16th). MidasGold, which will be available commercially in February 1996, is a dual-function electrophysiology and haemodynamic monitoring system. CardioWindow is an integrated cardiac workstation with multimedia capabilities which provides an electronic collection point for image, physiological and textual patient data. It links patient monitoring systems with advanced computing and networking capabilities.
You may also be interested in...
GNC hires Josh Burris as chief US officer; Clasado BioSciences adds Bellchambers as commercial director; and Barentz plans expansion with Cinven investment.
The House passage of a Democratic bill authorizing the federal government to negotiate drug prices in Medicare has sharpened the debate over how prices feed innovation, but the underlying policy stands little chance of being enacted without a Democratic wave in the next election. Pink Sheet's table highlights the key provisions of HR 3 and other pending pricing legislation.